论文部分内容阅读
目的:评价保妇康栓药物保守治疗宫颈上皮内瘤变Ⅱ级的疗效。方法:回顾性分析我院2006年至2010年间经阴道镜下宫颈多点活检诊断为CINⅡ并选择药物保守治疗的26例患者,分为使用保妇康栓组及干扰素栓组,比较两种药物治疗后随访期间的疗效。结果:经药物保守治疗病变逆转9例,其中7例为保妇康栓治疗组,2例为干扰素栓治疗组,随访2-6年未复发,17例患者随访期间改为LEEP手术治疗,保妇康栓与干扰素栓组分别为7例与10例。两组间的病变逆转率、病变持续率、病变进展率相比无统计学意义。结论:CINⅡ患者选择保妇康栓药物治疗,可促进病变逆转,但需要较长时间的随诊。
Objective: To evaluate the efficacy of Baofukang suppository in the conservative treatment of cervical intraepithelial neoplasia grade Ⅱ. Methods: A retrospective analysis of our hospital from 2006 to 2010 by cervical multipoint biopsy diagnosis of CIN Ⅱ and choose conservative treatment of 26 patients, divided into the use of Baofukang suppository group and interferon suppository group, compared two Efficacy during follow-up after drug treatment. Results: The conservative treatment of drug-induced lesions in 9 cases reversed, of which 7 cases of Baofukang suppository group, 2 cases of interferon suppository treatment group, followed up for 2-6 years without recurrence, 17 cases were followed up for LEEP surgery, Baofukang suppository and interferon suppository group were 7 cases and 10 cases. There was no significant difference between the two groups in the rate of lesion reversal, rate of lesion persistence, and rate of lesion progression. Conclusion: CIN Ⅱ patients choose Baofukang suppository therapy can promote the reversal of lesions, but requires a longer period of follow-up.